Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis
出版年份 2021 全文链接
标题
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis
作者
关键词
SARS-CoV-2, Mathematical model, COVID-19, Vaccination model, Optimisation
出版物
VACCINE
Volume 39, Issue 22, Pages 2995-3006
出版商
Elsevier BV
发表日期
2021-04-09
DOI
10.1016/j.vaccine.2021.04.002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients
- (2021) Sharon Amit et al. LANCET
- Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study
- (2021) Peter C Jentsch et al. LANCET INFECTIOUS DISEASES
- Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection
- (2021) Nick K Jones et al. eLife
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Fair Allocation of Scarce Medical Resources in the Time of Covid-19
- (2020) Ezekiel J. Emanuel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimating the burden of SARS-CoV-2 in France
- (2020) Henrik Salje et al. SCIENCE
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Estimates of the severity of coronavirus disease 2019: a model-based analysis
- (2020) Robert Verity et al. LANCET INFECTIOUS DISEASES
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
- (2020) Andrew Clark et al. Lancet Global Health
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- An ethical framework for global vaccine allocation
- (2020) Ezekiel J. Emanuel et al. SCIENCE
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Mohsen Naghavi et al. LANCET
- Immunosenescence: influenza vaccination and the elderly
- (2014) Kamran Haq et al. CURRENT OPINION IN IMMUNOLOGY
- Principles for allocation of scarce medical interventions
- (2009) Govind Persad et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now